Letko, Brosseau & Associates Inc Gilead Sciences, Inc. Transaction History

Letko, Brosseau & Associates Inc

  • $5.12 Billion
  • Q2 2024

A detailed history of Letko, Brosseau & Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 967,533 shares of GILD stock, worth $80.9 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
967,533
Previous 950,458 1.8%
Holding current value
$80.9 Million
Previous $69.6 Million 4.65%
% of portfolio
1.3%
Previous 1.23%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$63.15 - $72.88 $1.08 Million - $1.24 Million
17,075 Added 1.8%
967,533 $66.4 Million
Q1 2024

May 08, 2024
BUY
$71.58 - $87.29 $238,361 - $290,675
3,330 Added 0.35%
950,458 $69.6 Million
Q4 2023

Feb 12, 2024
SELL
$73.27 - $83.09 $1.74 Million - $1.98 Million
-23,787 Reduced 2.45%
947,128 $76.7 Million
Q3 2023

Nov 09, 2023
SELL
$73.94 - $80.67 $142,334 - $155,289
-1,925 Reduced 0.2%
970,915 $72.8 Million
Q2 2023

Aug 10, 2023
SELL
$76.01 - $86.7 $805,706 - $919,020
-10,600 Reduced 1.08%
972,840 $75 Million
Q1 2023

May 11, 2023
SELL
$77.31 - $88.08 $1.44 Million - $1.64 Million
-18,663 Reduced 1.86%
983,440 $81.6 Million
Q4 2022

Feb 10, 2023
SELL
$62.32 - $89.47 $20 Million - $28.7 Million
-320,320 Reduced 24.22%
1,002,103 $86 Million
Q3 2022

Nov 10, 2022
SELL
$59.54 - $68.01 $1.77 Million - $2.03 Million
-29,790 Reduced 2.2%
1,322,423 $81.6 Million
Q2 2022

Aug 09, 2022
BUY
$57.72 - $65.01 $10.8 Million - $12.2 Million
187,335 Added 16.08%
1,352,213 $83.6 Million
Q1 2022

May 11, 2022
SELL
$57.92 - $72.58 $1.27 Million - $1.59 Million
-21,893 Reduced 1.84%
1,164,878 $69.3 Million
Q4 2021

Feb 09, 2022
SELL
$64.88 - $73.64 $588,786 - $668,283
-9,075 Reduced 0.76%
1,186,771 $86.2 Million
Q3 2021

Nov 03, 2021
SELL
$67.69 - $73.03 $3.93 Million - $4.24 Million
-58,120 Reduced 4.63%
1,195,846 $83.5 Million
Q2 2021

Jul 29, 2021
SELL
$63.47 - $69.35 $646,759 - $706,676
-10,190 Reduced 0.81%
1,253,966 $86.3 Million
Q1 2021

May 11, 2021
BUY
$60.0 - $68.46 $7.62 Million - $8.69 Million
126,918 Added 11.16%
1,264,156 $81.7 Million
Q4 2020

Feb 05, 2021
SELL
$56.65 - $64.55 $7.8 Million - $8.88 Million
-137,644 Reduced 10.8%
1,137,238 $66.3 Million
Q3 2020

Nov 09, 2020
SELL
$62.1 - $78.08 $9.69 Million - $12.2 Million
-156,055 Reduced 10.91%
1,274,882 $80.6 Million
Q2 2020

Aug 07, 2020
SELL
$72.34 - $84.0 $8.56 Million - $9.94 Million
-118,275 Reduced 7.63%
1,430,937 $110 Million
Q1 2020

May 14, 2020
SELL
$62.63 - $80.22 $1.22 Million - $1.56 Million
-19,410 Reduced 1.24%
1,549,212 $116 Million
Q4 2019

Feb 07, 2020
BUY
$61.62 - $67.78 $10.2 Million - $11.2 Million
165,277 Added 11.78%
1,568,622 $102 Million
Q3 2019

Nov 05, 2019
BUY
$62.51 - $69.0 $1.58 Million - $1.75 Million
25,325 Added 1.84%
1,403,345 $88.9 Million
Q2 2019

Aug 01, 2019
SELL
$61.87 - $69.38 $2.51 Million - $2.81 Million
-40,561 Reduced 2.86%
1,378,020 $93.1 Million
Q1 2019

May 10, 2019
BUY
$62.53 - $70.05 $989,974 - $1.11 Million
15,832 Added 1.13%
1,418,581 $92.2 Million
Q4 2018

Feb 08, 2019
BUY
$60.54 - $79.0 $407,010 - $531,117
6,723 Added 0.48%
1,402,749 $87.7 Million
Q3 2018

Nov 08, 2018
SELL
$71.28 - $78.92 $2.28 Million - $2.53 Million
-32,020 Reduced 2.24%
1,396,026 $108 Million
Q2 2018

Aug 07, 2018
BUY
$64.88 - $75.68 $3.56 Million - $4.16 Million
54,925 Added 4.0%
1,428,046 $101 Million
Q1 2018

May 08, 2018
SELL
$72.84 - $88.8 $693,801 - $845,820
-9,525 Reduced 0.69%
1,373,121 $104 Million
Q4 2017

Feb 20, 2018
SELL
$71.15 - $83.52 $914,633 - $1.07 Million
-12,855 Reduced 0.92%
1,382,646 $99.1 Million
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $101 Million - $119 Million
1,395,501
1,395,501 $113 Million

Others Institutions Holding GILD

# of Institutions
1,879
Shares Held
1.02B
Call Options Held
12M
Put Options Held
8.96M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email